
The 'Dispatched' Podcast
BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.
Podcasting since 2021 • 165 episodes
The 'Dispatched' Podcast
Latest Episodes
The 'Dispatched' Week in Review'- 17 October
We discuss what could be a significant policy shift in PBS decision-making, with clinical judgement backed by what is a 'common sense' outcome. It could be a new precedent, but only if all stakeholders demand clarity on the criteria so that it ...
•
Season 4
•
Episode 35
•
39:26

The 'Dispatched' Week in Review - 12 October
Has Senate Estimates devolved into an overly polite, time-sliced format that enables waffle, obfuscation, and endless questions taken on notice? Does this reflect weakened scrutiny? The responses provided revealed the truth of review processes,...
•
Season 4
•
Episode 34
•
55:31

The Dispatched 'Week in Review' - 3 October
We open by marking Yom Kippur and a frank discussion before pivoting to the US 'MFN' drug-pricing moves, what they could mean for Australia’s PBS, and why institutional rigidity in HTA persists and is worsening. Medical research funding rhetori...
•
Season 4
•
Episode 33
•
53:01

The 'Dispatched' Week in Review - 26 September
On the Dispatched Podcast this week, we reflect on the erosion of public confidence in health decision-making. Former Victorian Chief Health Officer Brett Sutton’s admission that some COVID-19 measures were not strictly evidence-based ...
•
Season 4
•
Episode 32
•
52:25

The 'Dispatched' Week in Review - 12 September
In this week’s episode, the Medical Services Advisory Committee’s rejection of adding Pompe disease to newborn blood spot screening is condemned. The decision is contemptuous, inhumane, and riddled with fabricated justifications based on made-u...
•
43:12
